Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats

Objective To investigate the role of the deubiquitinase ubiquitin C-terminal hydrolase L1 (UCHL1) in hypertension and retinopathy in the spontaneously hypertensive rat (SHR). Methods Wistar–Kyoto (WKY) rats and SHRs were administered the UCHL1 inhibitor LDN57444 (20 μg/kg/day) for 4 months. Patholog...

Full description

Bibliographic Details
Main Authors: Shasha Liu, Chengfang Wang, Jianmin Lu, Guangzheng Dai, Huixin Che, Wei He
Format: Article
Language:English
Published: SAGE Publishing 2021-06-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605211020641
_version_ 1818402312122531840
author Shasha Liu
Chengfang Wang
Jianmin Lu
Guangzheng Dai
Huixin Che
Wei He
author_facet Shasha Liu
Chengfang Wang
Jianmin Lu
Guangzheng Dai
Huixin Che
Wei He
author_sort Shasha Liu
collection DOAJ
description Objective To investigate the role of the deubiquitinase ubiquitin C-terminal hydrolase L1 (UCHL1) in hypertension and retinopathy in the spontaneously hypertensive rat (SHR). Methods Wistar–Kyoto (WKY) rats and SHRs were administered the UCHL1 inhibitor LDN57444 (20 μg/kg/day) for 4 months. Pathological changes were detected with hematoxylin and eosin, immunofluorescence, and dihydroethidium staining. The mRNA and protein expression of UCHL1 were examined by real-time PCR and immunoblotting analysis. Results At 6 months of age, SHRs showed significantly increased mRNA and protein levels of UCHL1 in the retina compared with WKY rats. Moreover, SHRs exhibited significantly increased central retinal thickness, inflammation, and reactive oxygen species production compared with WKY rats, and these effects were markedly attenuated by systemic administration of the UCHL1 inhibitor LDN57444. The beneficial effects of LDN57444 were possibly associated with reduced blood pressure and the inactivation of several signaling pathways. Conclusion UCHL1 is involved in hypertension and retinopathy in SHRs, suggesting that UCHL1 may be used as a potential therapeutic target for treating hypertensive retinopathy.
first_indexed 2024-12-14T08:06:21Z
format Article
id doaj.art-bd9083155cc046a1b6e6e98445cbf9df
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-12-14T08:06:21Z
publishDate 2021-06-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-bd9083155cc046a1b6e6e98445cbf9df2022-12-21T23:10:10ZengSAGE PublishingJournal of International Medical Research1473-23002021-06-014910.1177/03000605211020641Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive ratsShasha LiuChengfang WangJianmin LuGuangzheng DaiHuixin CheWei HeObjective To investigate the role of the deubiquitinase ubiquitin C-terminal hydrolase L1 (UCHL1) in hypertension and retinopathy in the spontaneously hypertensive rat (SHR). Methods Wistar–Kyoto (WKY) rats and SHRs were administered the UCHL1 inhibitor LDN57444 (20 μg/kg/day) for 4 months. Pathological changes were detected with hematoxylin and eosin, immunofluorescence, and dihydroethidium staining. The mRNA and protein expression of UCHL1 were examined by real-time PCR and immunoblotting analysis. Results At 6 months of age, SHRs showed significantly increased mRNA and protein levels of UCHL1 in the retina compared with WKY rats. Moreover, SHRs exhibited significantly increased central retinal thickness, inflammation, and reactive oxygen species production compared with WKY rats, and these effects were markedly attenuated by systemic administration of the UCHL1 inhibitor LDN57444. The beneficial effects of LDN57444 were possibly associated with reduced blood pressure and the inactivation of several signaling pathways. Conclusion UCHL1 is involved in hypertension and retinopathy in SHRs, suggesting that UCHL1 may be used as a potential therapeutic target for treating hypertensive retinopathy.https://doi.org/10.1177/03000605211020641
spellingShingle Shasha Liu
Chengfang Wang
Jianmin Lu
Guangzheng Dai
Huixin Che
Wei He
Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats
Journal of International Medical Research
title Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats
title_full Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats
title_fullStr Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats
title_full_unstemmed Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats
title_short Long-term inhibition of UCHL1 decreases hypertension and retinopathy in spontaneously hypertensive rats
title_sort long term inhibition of uchl1 decreases hypertension and retinopathy in spontaneously hypertensive rats
url https://doi.org/10.1177/03000605211020641
work_keys_str_mv AT shashaliu longterminhibitionofuchl1decreaseshypertensionandretinopathyinspontaneouslyhypertensiverats
AT chengfangwang longterminhibitionofuchl1decreaseshypertensionandretinopathyinspontaneouslyhypertensiverats
AT jianminlu longterminhibitionofuchl1decreaseshypertensionandretinopathyinspontaneouslyhypertensiverats
AT guangzhengdai longterminhibitionofuchl1decreaseshypertensionandretinopathyinspontaneouslyhypertensiverats
AT huixinche longterminhibitionofuchl1decreaseshypertensionandretinopathyinspontaneouslyhypertensiverats
AT weihe longterminhibitionofuchl1decreaseshypertensionandretinopathyinspontaneouslyhypertensiverats